| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/12/2008 | CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | CA2670870A1 Antibacterial polycyclic urea compounds |
| 06/12/2008 | CA2670139A1 Indoles |
| 06/12/2008 | CA2669996A1 Pyrrol derivatives, preparation and use of the same in therapy |
| 06/12/2008 | CA2669829A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2669819A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2669590A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 06/12/2008 | CA2668558A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668517A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668515A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2667372A1 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulators |
| 06/12/2008 | CA2667210A1 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator |
| 06/12/2008 | CA2665924A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists |
| 06/11/2008 | EP1930329A1 1,3,5-triazine derivative, method for producing same, and organic electroluminescent device containing same as component |
| 06/11/2008 | EP1930325A1 Process for producing optically active piperazine compound |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930320A1 Novel fused pyrrole derivative |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1928862A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 06/11/2008 | EP1928861A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 06/11/2008 | EP1928860A1 Novel 2,3-dihydroindole compounds |
| 06/11/2008 | EP1928859A1 Pyrazole derivates as cannabinoid receptor modulators |
| 06/11/2008 | EP1928857A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 06/11/2008 | EP1928856A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 06/11/2008 | EP1928842A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 06/11/2008 | EP1928840A1 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta-hydroxysteroid dehydrogenase |
| 06/11/2008 | EP1928835A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 06/11/2008 | EP1928833A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 06/11/2008 | EP1928829A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/11/2008 | EP1928456A2 Substituted pyrazole compounds |
| 06/11/2008 | EP1928455A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/11/2008 | EP1601656A4 Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| 06/11/2008 | EP1556370B1 Method for the synthesis of a benzimidazole compound |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
| 06/11/2008 | EP1313713B1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | CN101198869A Agent for preventing and treating pancreatitis |
| 06/11/2008 | CN101198613A Substituted tetrahydroquinoline |
| 06/11/2008 | CN101198607A Phenylacetamides suitable as protein kinase inhibitors |
| 06/11/2008 | CN101198604A NPY antagonists, preparation and use |
| 06/11/2008 | CN101198601A Methods and intermediates for the preparation of optionally radio-labeled imatinib |
| 06/11/2008 | CN101198596A 2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases |
| 06/11/2008 | CN101198594A Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 06/11/2008 | CN101198330A Compositions of novel opioid compounds and method of use thereof |
| 06/11/2008 | CN101198253A Combinations, methods and compositions for treating cancer |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN100393789C Composition stablized to heat, oxidation or optical degradation stablized mixture and its preparation process |
| 06/11/2008 | CN100393714C Gyrase inhibitors and uses thereof |
| 06/11/2008 | CN100393713C Therapeutic agents useful for treating pain |
| 06/11/2008 | CN100393712C Improved preparation and separated purification method of benzimidazole type proton pump inhibitors and precursor thereof |
| 06/11/2008 | CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7384962 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | US7384961 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384946 M3 muscarinic acetylcholine receptor antagonists |
| 06/10/2008 | US7384945 Indole or benzimidazole derivatives as CB1 inverse agonists |
| 06/10/2008 | US7384944 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384939 N-(3,5-bis-trifluoromethyl-benzyl)-N-methyl-6-morpholin-4yl-4-o-tolyl-nicotinamide; inhibit interaction of substance P and neurokinin NK-1 receptor site; antiinflammatory; cyclization of amidoethyl-pyridinium salt with cyanoaryl-acrylate followed by amination, hydrogenation, hydrolysis; good yield |
| 06/10/2008 | US7384931 Constrained compounds as CGRP-receptor antagonists |
| 06/10/2008 | US7384930 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma |
| 06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/05/2008 | WO2008067465A1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 06/05/2008 | WO2008067390A2 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
| 06/05/2008 | WO2008067219A2 Quinazolinone modulators of tgr5 |
| 06/05/2008 | WO2008067120A2 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | WO2008066062A1 Anthrapyridone compound, salt thereof, magenta ink composition containing the same, and colored body |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065626A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| 06/05/2008 | WO2008065503A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 06/05/2008 | WO2008065500A2 Heteroaryl amides as type i glycine transport inhibitors |
| 06/05/2008 | WO2008064830A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses |
| 06/05/2008 | WO2008064823A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses |
| 06/05/2008 | WO2008064789A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
| 06/05/2008 | WO2008046085A3 Quinoline derivatives for modulating dna methylation |
| 06/05/2008 | WO2008043788A3 Novel compounds |
| 06/05/2008 | WO2008033857A3 Substituted amides, method of making, and method of use thereof |
| 06/05/2008 | US20080132707 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132562 Tetronic and tetramic acids |
| 06/05/2008 | US20080132550 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives; antiinflammatory agent, neurodegenerative diseases; inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease |
| 06/05/2008 | US20080132549 Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids |
| 06/05/2008 | US20080132548 Certain chemical entities, compositions, and methods |
| 06/05/2008 | US20080132547 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent |
| 06/05/2008 | US20080132546 e.g. Methyl 2-(6-{[(ethylamino)carbonyl]amino}pyridin-3-yl)-1,3-thiazole-5-carboxylate; bacterial DNA gyrase or bacterial topoisomerase IV inhibitor; antibacterial agent; antibiotic resistance; skin structure infections, pneumoniae, bronchitis, acute sinusitis, otitis media, sepsis, osteomyelitis |
| 06/05/2008 | US20080132545 Certain chemical entities, compositions, and methods |
| 06/05/2008 | US20080132540 Such as trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-N-(1-benzyl-piperidin-4-yl)-3-phenyl-acrylamide; for treating/preventing anxiolytic disorders/depression, injured mammalian nerve tissue, conditions, neurological disorders, bone loss, substance related disorders, and obesity; neuropeptide y (NPY Y2) |
| 06/05/2008 | US20080132524 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 06/05/2008 | US20080132523 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |